cholesterol
Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The high level of cholesterol in the blood is a marker of hypercholesterolemia, also called dyslipidemia. As a part of homeopathic product, it helps to support general liver and gallbladder health, and is used for temporary relief of symptoms related to adrenal glands such as fatigue and low energy. Cholesterol binds to and affects the gating of a number of ion channels such as the nicotinic acetylcholine receptor (nAChR) Inwardly-rectifying K+ channels (Kir); Transient receptor potential vanilloid 1 channels (TRPV1) and Large-conductance Ca2+-sensitive voltage-gated K+ channels (BK). It was shown the new mechanistic insights into the role of cholesterol in the regulation of nAChR, showing that cholesterol regulates the channels by two distinct mechanisms: stabilization of the channels in a resting state that depends on specific lipid-protein interactions and facilitation of the transitions between uncoupled and coupled states that depends on the hydrophobic thickness of the membrane — NCATS
Clinical trial activity
29 trials · 31 clinical orgs · 0 marketing orgs
Earliest trial started Jan 1, 1998 (NCT00272844)
Timeline
Indications
Approved for
Studied for
- Atherosclerosis · Phase 3
- Coronary Artery Disease · Phase 4
- Dyslipidemias · Phase 3
- Endothelial Cells · Phase 3
- Head and Neck Neoplasms · Phase 1
- Healthy Volunteers · Phase 4
- Hypercholesterolemia · Phase 3
- Hyperlipidemias · Phase 2/Phase 3
- Keratosis, Actinic · Phase 1/Phase 2
- Lipoproteins · Phase 2/Phase 3
- Musculoskeletal Diseases · Phase 2
- Prostatic Neoplasms · Phase 2
- Smith-Lemli-Opitz Syndrome · Phase 1/Phase 2
- Triglycerides · Phase 2/Phase 3
Mechanism of action
- Cell membraneMODULATOR
Cell membrane modulator
Chemistry & pharmacology
SMILES
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C- Mol. weight
- 386.6535 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCholesterol ↗
- NCATS97C5T2UQ7J ↗
- ChEMBLCHEMBL112570 ↗
Also known as
- 3h-cholesterol bound to albumin
- chinese red-yeast-rice dietary supplement
- cholesterin
- cholesterin
- cholesterol
- cholesterol
- cholesterol
- cholesterol
- cholestin
- cholestin
- cholestrin
- cholestrin
- crystalline cholesterol
- dc-cholesterol liposome
- red yeast rice
- red yeast rice
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04749784 | N/A | Oct 30, 2020 | analyze & realize GmbH, Perrigo |
| NCT04359823 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2020 | Medical University of South Carolina |
| NCT03618992 | N/A | Aug 31, 2018 | University of Arizona |
| NCT02969070 | Phase 3 | Nov 1, 2016 | University of Naples Frederico II |
| NCT02898805 | N/A | Jan 1, 2016 | University of Naples Frederico II |
| NCT02726555 | Phase 3 | Nov 1, 2015 | Wenzhou Medical University |
| NCT02492464 | N/A | May 1, 2015 | University of Bologna |
| NCT02603276 | N/A | Apr 1, 2015 | University of Bologna |
| NCT02257047 | N/A | Oct 1, 2014 | People's Liberation Army of China |
| NCT02001883 | Phase 4 | Nov 1, 2013 | University of Roma La Sapienza |
| NCT02295176 | N/A | Apr 1, 2013 | Rottapharm |
| NCT01687049 | Phase 2 | Jan 1, 2013 | University of Toronto |
| NCT01782027 | N/A | Oct 1, 2012 | University of Pennsylvania |
| NCT01527669 | Phase 4 | Feb 1, 2012 | Government of Taiwan, National Taiwan University |
| NCT01562080 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2012 | Centro Tecnológico de Nutrición y Salud, Rottapharm, Rovira i Virgili University, Universidad San Jorge, University of Valencia |
| NCT01269762 | Phase 4 | Jan 1, 2011 | Government of Taiwan, National Taiwan University |
| NCT01031758 | N/A | Nov 30, 2009 | AstraZeneca, University of Pennsylvania |
| NCT01031862 | N/A | Nov 30, 2009 | Bristol-Myers Squibb, University of Pennsylvania |
| NCT01152073 | N/A | Oct 1, 2009 | Boca Raton Community Hospital, Healthy Drink Discoveries, Inc. |
| NCT01087632 | N/A | Sep 1, 2009 | Rottapharm, University of Naples Frederico II |